Shorter therapy an option for high-risk anal cancer

Short-course radiotherapy, followed by brief chemotherapy, failed to improve the resection rate in advanced rectal cancer but demonstrated equivalence to conventional chemoradiation with less toxicity, a large randomized trial showed.
MedPage Today